4-(5-Methyl-1H-1,2,3-triazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine

ID: ALA4532636

PubChem CID: 142744339

Max Phase: Preclinical

Molecular Formula: C9H8N6

Molecular Weight: 200.21

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1[nH]nnc1-c1ncnc2[nH]ccc12

Standard InChI:  InChI=1S/C9H8N6/c1-5-7(14-15-13-5)8-6-2-3-10-9(6)12-4-11-8/h2-4H,1H3,(H,10,11,12)(H,13,14,15)

Standard InChI Key:  APJYRBBYCCSLBZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
   10.5356  -11.5240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2447  -11.9326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9496  -11.5240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9496  -10.7068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2447  -10.2982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5356  -10.7068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7268  -11.7745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7268  -10.4521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2070  -11.1154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6533   -8.2236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8361   -8.2236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5814   -9.0009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2447   -9.4810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9038   -9.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6810   -9.2514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  8  9  2  0
  7  9  1  0
  3  7  1  0
  4  8  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 10 14  1  0
 14 15  1  0
  5 13  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4532636

    ---

Associated Targets(Human)

JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 200.21Molecular Weight (Monoisotopic): 200.0810AlogP: 1.05#Rotatable Bonds: 1
Polar Surface Area: 83.14Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.94CX Basic pKa: 0.91CX LogP: 1.06CX LogD: 1.05
Aromatic Rings: 3Heavy Atoms: 15QED Weighted: 0.61Np Likeness Score: -1.01

References

1. Lee SM, Yoon KB, Lee HJ, Kim J, Chung YK, Cho WJ, Mukai C, Choi S, Kang KW, Han SY, Ko H, Kim YC..  (2016)  The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3.,  24  (21): [PMID:27555284] [10.1016/j.bmc.2016.08.008]

Source